Greater Cannabis Company (GCAN) Assets Average (2018 - 2026)
Greater Cannabis Company's (GCAN) quarterly Assets Average came in at $1127.0 in Q1 2026, down 97.83% year-on-year from $51999.0 in Q1 2025, and down 89.83% quarter-over-quarter from $11085.0 in Q4 2025.
Greater Cannabis Company (GCAN) Assets Average (2018 - 2026) Analysis & Trends
Greater Cannabis Company's Assets Average history runs 9 years deep, the most recent figure standing at $1127.0 for Q1 2026.
- On a quarterly basis, Assets Average fell 97.83% year-over-year to $1127.0 in Q1 2026; TTM through Mar 2026 was $1127.0, a 97.83% decrease from a year earlier, with the FY2025 full-year figure at $29300.0, down 74.53% from the prior year.
- Assets Average retreated to $1127.0 in Q1 2026 per GCAN's latest filing, from $11085.0 in the prior quarter.
- Across five years, Assets Average topped out at $387346.5 in Q1 2022 and bottomed at $1127.0 in Q1 2026.
- The 5-year median for Assets Average is $152883.0 (2024), against an average of $165039.8.
- Across the five-year window, Assets Average jumped 40.15% in 2022 and sank 97.83% in 2026, its largest moves.
- Year by year, Assets Average stood at $290604.0 in 2022, then tumbled by 34.88% to $189237.5 in 2023, then sank by 67.84% to $60867.0 in 2024, then tumbled by 81.79% to $11085.0 in 2025, then tumbled by 89.83% to $1127.0 in 2026.
- Per Business Quant, the three latest GCAN Assets Average figures stand at $1127.0 (Q1 2026), $11085.0 (Q4 2025), and $24033.5 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | 1,127.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,127.00 |
| Dec 31, 2025 | 11,085.00 |
| Sep 30, 2025 | 24,033.50 |
| Jun 30, 2025 | 36,462.50 |
| Mar 31, 2025 | 51,999.00 |
| Dec 31, 2024 | 60,867.00 |
| Sep 30, 2024 | 73,591.00 |
| Jun 30, 2024 | 108,361.50 |
| Mar 31, 2024 | 152,883.00 |
| Dec 31, 2023 | 189,237.50 |
| Sep 30, 2023 | 227,431.50 |
| Jun 30, 2023 | 254,692.00 |
| Mar 31, 2023 | 270,583.50 |
| Dec 31, 2022 | 290,604.00 |
| Sep 30, 2022 | 312,437.50 |
| Jun 30, 2022 | 352,935.00 |
| Mar 31, 2022 | 387,346.50 |
| Dec 31, 2021 | 451,356.00 |
| Sep 30, 2021 | 546,686.00 |
| Jun 30, 2021 | 478,118.00 |